Rossaphorn Kittiyawamarn,Pongtorn Chatpituck,Phalin Kamolwat et al.
Rossaphorn Kittiyawamarn et al.
The Lancet Hiv
The Lancet Hiv
Kaymarlin Govender,Olivier Mukuku,Jesper Sundewall
Kaymarlin Govender
Jonathan Shuter,Nancy A Rigotti,Krishna P Reddy et al.
Jonathan Shuter et al.
The increase in HIV pre-exposure prophylaxis (PrEP) uptake presents both challenges and opportunities. The process of initiating and continuing PrEP brings the medical care establishment into direct and ongoing contact with a young populati...
Ralph Hurley O&#x;Dwyer,Diego García Rodríguez,Ashwin Delmonte Sen et al.
Ralph Hurley O&#x;Dwyer et al.
Assessing the effectiveness of a depression-integrated model in adult HIV care in Uganda (the HIV+D trial): a cluster-randomised controlled trial [0.03%]
乌干达成人HIV护理中整合抑郁症治疗的有效性（HIV+D试验）：分层整群随机对照试验
Eugene Kinyanda,Leticia Kyohangirwe,Richard S Mpango et al.
Eugene Kinyanda et al.
Background: Although depression is common in people with HIV, mental health interventions are not available to the vast majority of people with HIV in Africa. We aimed to test the effectiveness of the HIV+D collaborative ...
Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir-rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study [0.03%]
长效注射卡博特格拉韦-利匹韦林在HIV-1感染且病毒学上抑制的青少年中的安全性、抗病毒活性和药代动力学：一项国际性I/II期单臂研究（IMPAACT 2017/MOCHA）：第48周结果
Aditya H Gaur,Kristin Baltrusaitis,Edmund V Capparelli et al.
Aditya H Gaur et al.
Background: Combined intramuscular long-acting cabotegravir-rilpivirine is the first long-acting combination antiretroviral therapy regimen approved for adults with HIV. The International Maternal Pediatric Adolescent AID...